Diagnostic and prognostic value of endothelin-1 plasma concentrations in dogs with heart and respiratory disorders

Veterinary Record

Volumn 158, Issue 23, 2006, Pages 783-788

  Tessier Vetzel, D ^a   Tissier, R ^a   Chetboul, V ^a   Carlos, C ^a   Nicolle, A ^a   Benbaron, D ^a   Dandrieux, J ^a   Thoulon, F ^b   Carayon, A ^c   Pouchelon, J L ^a  

^a ECOLE NATIONALE VÉTÉRINAIRE D ALFORT   (France)

^b Vétoquinol Laboratory   (France)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIN 1;

ANALYSIS OF VARIANCE; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD SAMPLING; CARDIOVASCULAR DISEASE; CHEMICAL ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DISEASE SEVERITY; DOG DISEASE; DOPPLER ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; HEART FAILURE; MALE; NONHUMAN; PROGNOSIS; PROTEIN BLOOD LEVEL; PULMONARY HYPERTENSION; RADIOIMMUNOASSAY; RESPIRATORY TRACT DISEASE; ROC CURVE; SYSTOLIC HYPERTENSION; THORAX RADIOGRAPHY;

ANIMALIA; CANIS FAMILIARIS;

EID: 33745433787     PISSN: 00424900     EISSN: None     Source Type: Journal    
DOI: 10.1136/vr.158.23.783     Document Type: Article

References (39)

1. ABRAMSON, S. V., BURKE, J. F., KELLY, J. J., Jr, KITCHEN, J. G., DOUGHERTY, M. J., YIH, D. F., MCGEEHIN, F. C., III, SHUCK, J. W. & PHIAMBOLIS, T. P. (1992) Pulmonary hypertension predicts mortality and morbidity in patients with dilated cardiomyopathy. Annals of Internal Medicine 116, 888-895
2. AGAPITOV, A. V. & HAYNES, W. G. (2002) Role of endothelin in cardiovascular disease. Journal of the Renin Angiotensin Aldosterone System 3, 1-15
3. BOON, J. A. (1998) Acquired heart disease, pulmonary hypertension. In Manual of Veterinary Echocardiography. Ed J. A. Boon. Baltimore, Williams & Wilkins. pp 342-352
4. CACOUB, P., DORENT, R., NATAF, P., CARAYON, A., RIQUET, M., NOE, E., PIETTE, J. C., GODEAU, P. & GANDJBACKH, I. (1993) Plasma endothelin and pulmonary pressures in patients with congestive heart failure. American Heart Journal 126, 1484-1488
5. CAVERO, P. G., MILLER, W. L., HEUBLEIN, D. M., MARGULIES, K. B. & BURNETT, J. C. (1990) Endothelin in experimental congestive heart failure in the anaesthetized dog. American Journal of Physiology 259, F312-F317
6. CHENG, C. P., UKAI, T., ONISHI, K., OHTE, N., SUZUKI, M., ZHANG, Z. S., CHENG, H. J., TACHIBANA, H., IGAWA, A., LITTLE, W. C. (2001) The role of ANG II and endothelin-1 in exercise-induced diastolic dysfunction in heart failure. American Journal of Physiology 280, H1853-H1860
7. CODY, R. J., HAAS, G. J., BINKLEY, P. F., CAPERS, Q. & KELLEY, R. (1992) Plasma endothelin correlates with the extent of pulmonary hypertension in patients with chronic congestive heart failure. Circulation 85, 504-509
8. DOHI, K., ONISHI, K., KITAMURA, T., OKINAKA, T., ITO, M., ISAKA, N. & NAKANO, T. (2001) Functional role of endogenous endothelin-1 in congestive heart failure treated with angiotensin II receptor antagonist. Japanese Journal of Physiology 41, 445-453
9. DONCKIER, J. E., HANET, C., BERBINSCHI, A., GALANTI, L., ROBERT, A., VAN MECHELEN, H., POULEUR, H. & KETELSLEGERS, J. M. (1991) Cardiovascular and endocrine effects of endothelin-1 at pathophysiological plasma concentrations in conscious dogs. Circulation 84, 2476-2484
10. GALATIUS-JENSEN, S., WROBLEWSKI, H., EMMELUTH, C., BIE, P., HAUNSO, S. & KASTRUP, J. (1996) Plasma endothelin in congestive heart failure: effect of the ACE inhibitor, fosinopril. Cardiovascular Research 32, 1148-1154
11. GIAID, A., YANAGISAWA, M., LANGLEBEN, D., MICHEL, R. P., LEVY, R., SHENNIB, H., KIMURA, S., MASAKI, T., DUGUID, W. P. & STEWERT, D. J. (1993) Expression of endothelin-1 in the lungs of patients with pulmonary hypertension. New England Journal of Medicine 328, 1732-1739
12. HEUBLEIN, D. M., MILLER, W., CAVERO, P. G. & BURNETT, J. C., Jr (1989) Presence of endothelin in human and canine plasma. Journal of the American Society of Hypertension 4, 211A
13. HULSMANN, M., STANEK, B., FREYB, M., STURM, B., PUTZ, D., KOS, T., BERGER, R., WOLOSZCZUK, W., PUTZ, D., KOS, T., BERGER, R., WOLOSZCZUK, W., MAURER, G. & PACHER, R. (1998) Value of cardiopulmonary exercise testing and big endothelin plasma levels to predict short-term prognosis of patients with chronic heart failure. Journal of American College of Cardiology 32, 1695-1700
14. ISACHC (1999) Recommendations for diagnosis of heart disease and treatment of heart failure in small animals. In Textbook of Canine and Feline Cardiology, Principles and Clinical Practice. 2nd edn. Eds P. R. Fox, D. Sisson, N. S. Moise. Philadelphia, W. B. Saunders. pp 883-901
15. LEE, J. H., CHUN, Y. G., LEE, I. C., TUDER, R. M., HONG, S. B., SHIM, T. S. LIM, C. M., KOH, Y., KIM, W. S., KIM, D. S., KIM, W. D. & LEE, S. D. (2001) Pathogenic role of endothelin 1 in hemodynamic dysfunction in experimental acute pulmonary thromboembolism. American Journal of Respiratory and Critical Care Medicine 164, 1282-1287
16. MCMURRAY, J., DAVIE, A. P. & MCCLURE, S. J. (1997) Assessment of heart failure with plasma natriuretic peptides. Lancet 350, 1349-1353
17. MCMURRAY, J. J., RAY, S. G., ABDULLAH, I., DARGIE, H. J. & MORTON, J. J. (1992) Plasma endothelin in chronic heart failure. Circulation 85, 504-509
18. MARGULIES, K. B., HILDEBRAND, F. L., LERMAN, A., PERELLA, M. A. & BURNETT, J. C. (1990) Increased endothelin in experimental heart failure. Circulation 82, 2226-2230
19. MONGE, J. C. (1998) Neurohormonal markers of clinical outcome in cardiovascular disease: is endothelin the best one? Journal of Cardiovascular Pharmacology 32, S36-S42
20. MORAES, D. L., COLUCCI, W. S. & GIVERTZ, M. M. (2000) Secondary pulmonary hypertension in chronic heart failure. The role of endothelium in pathophysiology and management. Circulation 102, 1718-1723
21. MOTTE, S. VAN BENEDEN, R., MOTTET, J., RONDELET, B., MATHIEU, M., HAVAUX, X., LAUSE, P., CLERCX, C., KETELSLEGERS, J. M., NAEIJE, R., MCENTEE, K. (2003) Early activation of cardiac and renal endothelin systems in experimental heart failure. American Journal of Physiology, Heart and Circulation Physiology 285, H2482-H2491
22. MUDERS, F., KROMER, E. P., GRIESE, D. P., PFEIFER, M., HENSE, H. W., RIEGGER, G. A. & ELSNER, D. (1997) Evaluation of plasma natriuretic peptides as markers for left ventricular systolic dysfunction. American Heart Journal 134, 442-449
23. PORTER, T. R., TAYLOR, D. O., CYCAN, A., FIELDS, J., BEGLEY, C. W., PANDIAN, N. G. & MOHANTY, P. K. (1993) Endothelium-dependent pulmonary artery responses in chronic heart failure: influence of pulmonary hypertension. Journal of the American College of Cardiology 22, 1418-1424
24. POUSSET, F., ISNARD, R., TROCHU, J., CHAFIROVSKAIA, O., CARAYON, A., GOLMARD, J., LECHAT, P., THOMAS, D., BOUHOUR, J. & KOMAJDA, M. (1997) Prognostic value of plasma endothelin-1 in patients with chronic heart failure. European Heart Journal 18, 254-258
25. RICKENBACHER, P. R., TRINDADE, P. T., HAYWOOD, G. A., VAGELOS, R. H., SCHROEDER, J. S., WILLSON, K., PRIKAZSKY L. & FOWLER, M. B. (1996) Transplant candidates with severe left ventricular dysfunction managed with medical treatment: characteristics and survival. Journal of the American College of Cardiology 27, 1192-1197
26. RODEHEFFER, R. J., LERMAN, A., HEUBLEIN, D. M. & BURNETT, J. C. (1992) Increased plasma concentrations of endothelin in congestive heart failure in humans. Mayo Clinical Proceedings 67, 719-724
27. ROSSI, G. P., CAVALLIN, M., NUSSDORFER, G. G. & PESSINA, A. C. (2001) The endothelin-aldosterone axis and cardiovascular diseases. Journal of Cardiovascular Pharmacology 38, S49-S52
28. RUBANYI, G. M. & POLOKOFF, M. A. (1994) Endothelins: molecular biology, biochemistry, pharmacology, physiology and pathophysiology. Pharmacology Review 46, 325-415
29. RUBENS, C., EWERT, R., HALANK, M., WENSEL, R., ORZECHOWSKI, H. D., SCHULTHEISS, H. P. & HOEFFKEN, G. (2001) Big endothelin-1 and endothelin-1 plasma levels are correlated with the severity of primary pulmonary hypertension. Chest 120, 1562-1569
30. SAHN, D. J., DEMARIA, A., KISSLO, J. & WEYMAN, A. (1978) Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 58, 1072-1083
31. SCAPELLATO, F., TEMPORELLI, P. L., ELEUTERI, E., CORRA, U., IMPARATO, A. & GIANNUZZI, P. (2001) Accurate noninvasive estimation of pulmonary vascular resistance by Doppler echocardiography in patients with chronic heart failure. Journal of the American College of Cardiology 37, 1813-1819
32. SELVAIS, P. L., ROBERT, A., AHN, S., VAN LINDEN, F., KETELSLEGERS, J. M., POULEUR, H. & ROUSSEAU, M. F. (2000) Direct comparison between endothelin-1, N-terminal proatrial natriuretic factor and brain natriuretic peptide as prognostic markers of survival in congestive heart failure. Journal of Cardiac Failure 6, 201-207
33. SISSON, D. (2000) The diagnostic potential of natriuretic peptides in heart failure. Journal of Veterinary Cardiology 2, 5-6
34. STEWART, D. J., LEVY, R. D., CARNACEK, P. & LANGLEBEN, D. (1991) Increased plasma endothelin-1 in pulmonary hypertension: marker or mediator of disease? Annals of Internal Medicine 114, 464-469
35. TADANO, K., SUZUKI, J., HANADA, K., NAKAO, R., UEHARA, S., OHTA, H., MIYAUCHI, T. & NISHIKIBE, M. (2001) Pathophysiological roles of endogenous endothelin-1 in dogs with chronic heart failure produced by rapid right ventricular pacing. Journal of Pharmacology and Experimental Therapeutics 298, 729-736
36. THOMAS, W. P., GABER, C. E., JACOBS, G. J., KAPLAN, P. M., LOMBAR, C. W., MOISE, N. S. & MOSES, B. L. (1993) Recommendations for standards in transthoracic two-dimensional echocardiography in the dog and cat. Echocardiography Committee of the Specialty of Cardiology, American College of Veterinary Internal Medicine. Journal of Veterinary Internal Medicine 7, 247-252
37. VIERHAPPER, H., WAGNER, O., NOWOTNY, P. & WALDHAUSI, W. (1990) Effect of endothelin-1 in man. Circulation 81, 1415-1418
38. VOLLMAR, A. M., PREUSSER, U., GERBES, A. L., KRAFT, W. & SCHULZ, R. (1995) Endothelin concentration in plasma of healthy dogs and dogs with congestive heart failure, renal failure, diabetes mellitus and hyperadrenocorticism. Journal of Veterinary Internal Medicine 9, 105-111
39. WANG, X., OHNISHI, M., WADA, A., TSUTAMOTO, T., SAWAKI, M., MATSUMOTO, T., YAMAMOTO, T., KUROKAWA, K., YAMADA, H. & KINOSHITA, M. (2001) Endothelin-1 promotes vascular structural remodeling during the progression of heart failure prevention of vascular remodeling using a specific endothelin-converting enzyme inhibitor. Life Sciences 69, 2477-2488